A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs

被引：7
|
作者：
Gerona, Roy [1 ]
Wen, Anita [1 ]
Koss, Catherine [2 ]
Bacchetti, Peter [3 ]
Gandhi, Monica [2 ]
Metcalfe, John [4 ]
机构：
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Maternal Fetal Med Div, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Curry Int TB Ctr, San Francisco, CA USA
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2016年 / 20卷 / 07期
关键词：
D O I：
10.5588/ijtld.16.0201
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：991 / 992
页数：2
相关论文
共 50 条
  • [1] Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods
    Sirgel, FA
    Maritz, JS
    Venter, A
    Langdon, G
    Smith, PJ
    Donald, PR
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (02) : 182 - 187
  • [2] GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs
    Theron, Grant
    Peter, Jonny
    Richardson, Marty
    Warren, Rob
    Dheda, Keertan
    Steingart, Karen R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (09):
  • [3] Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy
    Fattorini, Lanfranco
    Migliori, Giovanni Battista
    Cassone, Antonio
    Mustazzolu, Alessandro
    Piccaro, Giovanni
    Filippini, Perla
    Cirillo, Daniela Maria
    Borroni, Emanuele
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (05) : 1263 - 1266
  • [4] Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs
    Ranjan, Rajeev
    Srivastava, Ashish
    Bharti, Reena
    Ray, Lipika
    Singh, Jyotsna
    Misra, Amit
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 547 (1-2) : 150 - 157
  • [5] A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
    Goodison, Steve
    Chang, Myron
    Dai, Yunfeng
    Urquidi, Virginia
    Rosser, Charles J.
    PLOS ONE, 2012, 7 (10):
  • [6] Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance
    Kam, K. M.
    Sloutsky, A.
    Yip, C. W.
    Bulled, N.
    Seung, K. J.
    Zignol, M.
    Espinal, M.
    Kim, S. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (03) : 282 - 288
  • [7] Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs
    Said, H. M.
    Kock, M. M.
    Ismail, N. A.
    Baba, K.
    Omar, S. V.
    Osman, A. G.
    Hoosen, A. A.
    Ehlers, M. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (01) : 104 - 109
  • [8] High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia
    Jugheli, L.
    Rigouts, L.
    Shamputa, I. C.
    de Rijk, W. Bram
    Portaels, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (05) : 561 - 566
  • [9] Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia
    Chizimu, Joseph Yamweka
    Solo, Eddie Samuneti
    Bwalya, Precious
    Kapalamula, Thoko Flav
    Mwale, Kaemba Kunkuta
    Squarre, David
    Shawa, Misheck
    Lungu, Patrick
    Barnes, David Atomanyi
    Yamba, Kaunda
    Mufune, Tiza
    Chambaro, Herman
    Kamboyi, Harvey
    Munyeme, Musso
    Hang'ombe, Bernard Mudenda
    Kapata, Nathan
    Mukonka, Victor
    Chilengi, Roma
    Thapa, Jeewan
    Nakajima, Chie
    Suzuki, Yasuhiko
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [10] Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
    Wu, Chunli
    Yi, Hengzhong
    Hu, Yanmei
    Luo, Danlin
    Tang, Zhigang
    Wen, Xinmin
    Zhang, Yong
    Tang, Mi
    Zhang, Lizhi
    Wu, Shu
    Chen, Mengshi
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
12345